Medical/Pharmaceuticals
Fosun International Granted Three Awards from Global Banking and Finance Review in the United Kingdom
HONG KONG, Dec. 23, 2022 /PRNewswire/ -- On 23 December 2022, Fosun International was notified byGlobal Banking and Finance Review, a famous financial magazine in theUnited Kingdom, that Fosun International was granted three awards, namely "Brand of the Year Awards - Holding Group Brand of the Y...
2022-12-23 10:52
4446
JUNIPER BIOLOGICS WINS M&A AWARD 2022 BY ACQUISITION INTERNATIONAL
Best Cell & Gene Therapy Acquisition 2022: Juniper Biologics/Kolon Life Science
SINGAPORE, Dec. 23, 2022 /PRNewswire/ -- Singapore-headquartered Juniper
Biologics Pte Ltd
2022-12-23 09:35
3118
Antengene Announces NDA Submission for XPOVIO® in Macau, Malaysia and Thailand for Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Diffuse Large B-cell Lymphoma
SHANGHAI and HONG KONG, Dec. 23, 2022 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hem...
2022-12-23 08:30
3435
P3 Research secures investment from Genesis Capital to accelerate expansion
* P3 is a leading New Zealand clinical trial site network founded in 1998 * With sites in seven locations throughout New Zealand, P3's clients range from large multi-nationals to small biotechs globally * Genesis Capital has become the major shareholder of the clinical trials group alongside...
2022-12-22 19:36
3154
New STIC trial data shows longer overall survival for therapy selection based on CELLSEARCH® CTC count in patients with metastatic breast cancer
Integration of CTC (Circulating Tumor Cell) enumeration* to decide between endocrine therapy and chemotherapy may lead to improved clinical outcomes and quality of life for patients with oestrogen receptor (ER) positive)/human epidermal growth factor receptor (HER) 2 negative metastatic breast ca...
2022-12-22 16:00
4281
Gemini Rosemont adds Peninsula Life Science Center eight-story office building to portfolio in all cash transaction
LOS ANGELES, Dec. 22, 2022 /PRNewswire/ -- Gemini Rosemont Commercial Real
Estate, a vertically integrated real estate investment management firm
specializing in Class A multi-tenant office and luxury residential properties,
has acquired Peninsula Life Science Center for$59,350,000.
2022-12-22 11:27
5143
Everest Medicines' Licensing Partner Pfizer Announces FDA and EMA Acceptance of Etrasimod Regulatory Submissions for Ulcerative Colitis
SHANGHAI, Dec. 22, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK) announced today that its licensing partner, Pfizer Inc. (NYSE: PFE) has received acceptance from the U.S. Food and Drug Administration (FDA) for review a New Drug Application (NDA) for etrasimod for individuals living with ...
2022-12-22 08:00
4266
ZIRCON Phase III Renal Cancer Study to be Presented at ASCO GU along with Theranostic Pipeline Advances
* Complete data from global Phase III ZIRCON study of Telix's investigational imaging agent TLX250-CDx in clear cell renal cell carcinoma (ccRCC) will be presented at American Society of Clinical Oncology (ASCO) Genitourinary (GU) Cancers Symposium (ASCO GU) inFebruary 2023 * Telix pipeline...
2022-12-22 06:04
2449
Medidata awarded International Innovation Award for Medidata Sensor Cloud
SINGAPORE, Dec. 21, 2022 /PRNewswire/ -- For the third consecutive year, Medidata, a Dassault Systèmes company, was awarded the International Innovation Award. This year, the Medidata Sensor Cloud won the award under the Service and Solution category. Sensor Cloud provides cutting-edge data inges...
2022-12-21 14:44
2283
PeproMene Bio, Inc. Announced Complete Response of The First Patient Treated in Its B-cell Non-Hodgkin Lymphoma (B-NHL) Phase 1 Clinical Trial of PMB-CT01 (BAFFR-CAR T Cells) at City of Hope
IRVINE, Calif., Dec. 21, 2022 /PRNewswire/ -- PeproMene Bio, Inc., a clinical-stage biotech company developing novel therapies to treat cancers and immune disorders, today announced that the first patient treated in its phase 1 relapsed or refractory B-cell Non-Hodgkin Lymphoma (r/r B-NHL) clinic...
2022-12-21 09:00
2327
Ascletis' NASH Drug ASC41(THRβ) Phase II Enrollment is Progressing as Planned
HANGZHOU and SHAOXING, China, Dec. 21, 2022 /PRNewswire/ -- The enrollment of the 52-week Phase II clinical trial of thyroid hormone receptor β (THRβ) agonist ASC41 developed in house by Gannex Pharma Co., Ltd., a wholly owned subsidiary of Ascletis Pharma Inc. (HKEX: 1672, "Ascletis"), for tr...
2022-12-21 08:00
2806
Sirnaomics Announces Interim Data from Phase I Clinical Trial of RNAi Therapeutic STP707 for Treatment of Multiple Solid Tumors
First three out of five cohorts pass safety requirements, allowing the Company to dose additional cohorts to assess safety, tolerability, pharmacokinetics and anti-tumor activity HONG KONG, GERMANTOWN, Md., and SUZHOU, China, Dec. 21, 2022 /PRNewswire/ -- Sirnaomics Ltd.(Stock Code: 2257.HK) (th...
2022-12-21 00:39
3421
Sanisure Announces the Acquisition of a Leading Silicone Extrusion Facility in Twinsburg, Ohio
CAMARILLO, Calif., Dec. 21, 2022 /PRNewswire/ -- Sanisure, a leading, vertically-integrated player in the single- use bioprocessing technology space, is pleased to announce the acquisition of Medical Elastomer Development, Inc ("MED") a silicone extrusion facility from Q Holding, a 3i portfolio c...
2022-12-21 00:06
2289
AstraZenca, G42 Healthcare enter strategic partnership to manufacture pharmaceutical products in Abu Dhabi
ABU DHABI, UAE, Dec. 20, 2022 /PRNewswire/ -- Building on the ongoing efforts of the Department of Health –Abu Dhabi (DoH) in spearheading Abu Dhabi's healthcare ecosystem, AstraZeneca, a science-led biopharmaceutical and one of the top 10 biopharma companies globally, and G42 Healthcare, an AI-p...
2022-12-20 23:16
2586
Kira Pharmaceuticals Announces Clearance to Initiate Phase 2 Evaluation of KP104 in IgA Nephropathy (IgAN) and Complement 3 Glomerulopathy (C3G) in China and Australia
CAMBRIDGE, Mass., Dec. 20, 2022 /PRNewswire/ -- Kira Pharmaceuticals, a global biotechnology company pioneering transformational complement therapies to treat immune-mediated diseases, announced today that the Chinese National Medical Products Administration (NMPA) and the Australian Therapeutic ...
2022-12-20 20:00
2552
Mentice AB (publ) receives an order of 1,1 million USD for simulation solutions from Beijing Huanya Zhitong on behalf of the Chinese Medical Education Association.
GOTHENBURG, Sweden, Dec. 20, 2022 /PRNewswire/ -- Mentice AB (publ), Gothenburg , a world leader in simulation solutions for image-guided interventional therapies, announced today that Beijing Huanya Zhitong,Beijing, China, has signed an agreement to acquire Mentice VIST® simulation solutions for ...
2022-12-20 00:35
1645
Carrick Therapeutics and The Menarini Group Announce Clinical Trial Collaboration to Evaluate Samuraciclib and Elacestrant Combination
Carrick to execute Phase 2 clinical trial in patients with CDK4/6i resistant HR+, HER2- metastatic breast cancer DUBLIN and FLORENCE, Italy, Dec. 19, 2022 /PRNewswire/ -- Carrick Therapeutics, an oncology-focused biopharmaceutical company discovering and developing highly differentiated therapie...
2022-12-19 23:07
2395
Carcell welcomes Prof. Harvey Lodish as Chair of its Scientific Advisory Board
SINGAPORE and SHANGHAI, Dec. 19, 2022 /PRNewswire/ -- Carcell Biopharma
2022-12-19 22:00
2033
Health and Hydrogen launches one of the first medical-grade Molecular Hydrogen Inhalation Machine HAH-301
GURGAON, India, Dec. 19, 2022 /PRNewswire/ -- Molecular Hydrogen Inhalation
therapy is now extensively used for its many health benefits, such as reducing
inflammation, improving cellular function, and protecting against oxidative
stress.Health And Hydrogen
2022-12-19 21:01
2875
China and ASEAN Deepened Exchanges and Cooperation on Traditional Medicine
BEIJING, Dec. 19, 2022 /PRNewswire/ -- A report from CRIOnline: From December 11 to 13, the 7th China-ASEAN Forum on Traditional Medicine was held in Fangchenggang City,Guangxi, China. China-ASEAN Forum on Traditional Medicine is held every two years. With the theme of "Seizing RCEP Opportunitie...
2022-12-19 20:01
2417
Week's Top Stories
Most Reposted
LONG AN INTERNATIONAL PORT JOINS 12TH PORTECH ASIA SUMMIT 2025 IN MALAYSIA
[Picked up by 335 media titles]
2025-01-18 03:30
Hong Kong Airlines Takes Off to Australia's Gold Coast Bringing Popular Travel Option for the Chinese New Year
[Picked up by 309 media titles]
2025-01-18 17:00
HARD ROCK HOTEL BALI ACHIEVES PRESTIGIOUS GSTC CERTIFICATION
[Picked up by 306 media titles]
2025-01-20 14:27
dss⁺ Announces Strategic Changes to Executive Leadership Team in Asia Pacific Accelerating growth and impact for high-hazard industries in the region
[Picked up by 305 media titles]
2025-01-21 16:00
Supported by the Luxembourg Government, The Luxembourg House of Financial Technology (LHoFT) and the Asian Development Bank (ADB) Announce the 2nd Edition of Catapult | SE Asia 2025
[Picked up by 302 media titles]
2025-01-22 15:38
Most Read
LONG AN INTERNATIONAL PORT JOINS 12TH PORTECH ASIA SUMMIT 2025 IN MALAYSIA
2025-01-18 03:30
11066
Hong Kong Airlines Takes Off to Australia's Gold Coast Bringing Popular Travel Option for the Chinese New Year
2025-01-18 17:00
10032
Boosting Yeast Protein Production to Meet the Growing Global Demand for Alternative Proteins
2025-01-17 22:46
9507
Dongying's vibrant Spring Festival awaits visitors
2025-01-17 21:46
9397